» Articles » PMID: 2177205

Action of Chlormethiazole in a Model of Ethanol Withdrawal

Overview
Specialty Pharmacology
Date 1990 Jan 1
PMID 2177205
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Mice withdrawn from exposure for 14 days to ethanol inhalation showed the expected signs of ethanol withdrawal including convulsive behaviour. Injection of chlormethiazole (100 mg/kg) 5 h after the start of withdrawal, at the time that the convulsive behaviour was near maximal, resulted in the virtual disappearance of the withdrawal-induced behaviour within 30 min, with its reappearance by 60 min. A dose of chlormethiazole of 40 mg/kg was without effect. The time course of the effect of chlormethiazole (100 mg/kg) in the withdrawal test was similar to its effect in raising seizure threshold and decreasing locomotor activity. Chlormethiazole did not alter in vitro binding of [3H]-PN 200-110 to the dihydropyridine sensitive Ca2+ channel. Chlormethiazole, a drug used clinically to treat ethanol withdrawal, has therefore been shown to be effective in this animal model of withdrawal. Dihydropyridine calcium antagonists are also active in the model but chlormethiazole is likely to work by a different mechanism and it is suggested that this may be by increasing GABAergic function.

Citing Articles

Poster communications.

Br J Pharmacol. 2008; 109(Suppl):67P-142P.

PMID: 19108269 PMC: 2175552.


Update on the neurobiology of alcohol withdrawal seizures.

Rogawski M Epilepsy Curr. 2005; 5(6):225-30.

PMID: 16372057 PMC: 1312739. DOI: 10.1111/j.1535-7511.2005.00071.x.


Possible involvement of NMDA receptor-mediated transmission in barbiturate physical dependence.

Rabbani M, Wright J, Butterworth A, Zhou Q, Little H Br J Pharmacol. 1994; 111(1):89-96.

PMID: 7912157 PMC: 1910034. DOI: 10.1111/j.1476-5381.1994.tb14028.x.


Effects of diltiazem in convulsive states differ from those previously reported for dihydropyridine calcium channel antagonists.

Watson W, Little H Psychopharmacology (Berl). 1994; 114(2):321-8.

PMID: 7530854 DOI: 10.1007/BF02244855.


The differential effects of felodipine and nitrendipine on cerebral dihydropyridine binding ex vivo and the ethanol withdrawal syndrome in mice.

Watson W, Misra A, Cross A, Green A, Little H Br J Pharmacol. 1994; 112(4):1017-24.

PMID: 7524989 PMC: 1910238. DOI: 10.1111/j.1476-5381.1994.tb13184.x.


References
1.
Moody E, Skolnick P . Chlormethiazole: neurochemical actions at the gamma-aminobutyric acid receptor complex. Eur J Pharmacol. 1989; 164(1):153-8. DOI: 10.1016/0014-2999(89)90242-2. View

2.
Cross A, Stirling J, Robinson T, Bowen D, Francis P, Green A . The modulation by chlormethiazole of the GABAA-receptor complex in rat brain. Br J Pharmacol. 1989; 98(1):284-90. PMC: 1854653. DOI: 10.1111/j.1476-5381.1989.tb16893.x. View

3.
Liljequist S, Culp S, Tabakoff B . Effect of ethanol on the binding of 35S-T-butylbicyclophosphorothionate to mouse brain membranes. Life Sci. 1986; 38(21):1931-9. DOI: 10.1016/0024-3205(86)90222-5. View

4.
Jostell K, Fagan D, Bjork M, Broberg F, Mitchell R, Scott D . The bioavailability and pharmacodynamics of chlormethiazole in healthy young and elderly volunteers: preliminary findings. Acta Psychiatr Scand Suppl. 1986; 329:32-3. DOI: 10.1111/j.1600-0447.1986.tb10532.x. View

5.
Burroughs A, Morgan M, Sherlock S . Double-blind controlled trial of bromocriptine, chlordiazepoxide and chlormethiazole for alcohol withdrawal symptoms. Alcohol Alcohol. 1985; 20(3):263-71. View